期刊文献+

非睡眠剥夺情况下水合氯醛用于眼科患儿镇静适合剂量的探讨 被引量:7

Exploration on appropriate sedation dose of chloral hydrate for children in ophthalmology department under non-sleep-deprived condition
下载PDF
导出
摘要 目的 探讨非睡眠剥夺情况下水合氯醛用于眼科患儿镇静的适合剂量. 方法 接受眼科检查需实施镇静的患儿120例,ASAⅠ-Ⅱ级,年龄1个月-3岁. 按照年龄分为婴儿组(1-12个月)和幼儿组(1-3岁),再按口服水合氯醛的剂量随机分为4组:婴儿1组:给予10%水合氯醛0. 5 mL/kg;婴儿2组:给予10%水合氯醛1 mL/kg;幼儿1组:给予10%水合氯醛0. 5 mL/kg;幼儿2组:给予10%水合氯醛1 mL/kg. 记录患儿服用水合氯醛后的入睡时间、入睡后脑电双频指数( BIS)及镇静失败率. 记录实施镇静时整个过程中患儿呛咳反应、呼吸抑制及恶心呕吐等不良反应的发生情况. 结果 婴儿 1 组与婴儿 2 组比较,婴儿 2 组入睡时间缩短(P〈0. 05),镇静失败率变化差异无统计学意义(P〉0. 05);幼儿1组与幼儿2组比较,幼儿2组入睡时间缩短且镇静失败率降低(P〈0. 05);各组间BIS、各项不良反应发生情况及检查时间比较差异无统计学意义(P〉0. 05).结论 非睡眠剥夺情况下水合氯醛用于眼科婴儿的镇静适合剂量为0. 5 mL/kg,用于幼儿的适合剂量为1 mL/kg,适合剂量下均可达到满意的镇静深度,且无明显不良反应发生. Objective To explore the appropriate dose of chloral hydrate for children in ophthalmology depart-ment under non-sleep-deprived condition. Methods One hundred and twenty cases of children,who required sedation for ophthalmologic examination with ASAⅠ~ Ⅱand aged from 1 month to 3 years were chosen. According to their a-ges,the children were divided into the infant group (1~12 months) and children group (1~3 years),who were fur-ther randomly divided into 4 groups according to the doses of oral chloral hydrate,the infant group 1 was given 10%0. 5 mL/kg chloral hydrate,the infant group 2 was given 10% 1 mL/kg chloral hydrate,the children group 1 was given 10% 0. 5 mL/kg chloral hydrate,and the children group 2 was given 10% 1 mL/kg chloral hydrate. The sleep latency,bispectral index ( BIS ) after sleep onset and sedation failure rate were recorded after children took chloral hy-drate. During the whole process of sedation,cough reflex,respiratory depression,nausea and vomiting and other adversereactions in children were recorded. Results Compared with infant group 1,the sleep latency in the infant group 2 was reduced (P〈0. 05),but the difference in sedation failure rate was not statistically significant (P〉0. 05). Compared with children group 1,both the sleep latency and sedation failure rate in the children group 2 were reduced (P〈0. 05). The differences in BIS,various adverse reactions and inspection time between different groups were not statistically sig-nificant (P〉0. 05). Conclusion The appropriate dose of chloral hydrate for infants in ophthalmology department un-der non-sleep-deprived condition is 0. 5 mL/kg,and that for the children is 1 mL/kg. These appropriate doses are asso-ciated with satisfactory sedation degree and absence of obvious adverse reactions.
出处 《实用药物与临床》 CAS 2015年第10期1204-1206,共3页 Practical Pharmacy and Clinical Remedies
关键词 水合氯醛 非睡眠剥夺 婴幼儿 镇静 Chloral hydrate Non-sleep-deprived Infants and children Sedation
  • 相关文献

参考文献10

  • 1徐燕,卞薇.婴幼儿眼科检查前应用水合氯醛的技巧[J].临床眼科杂志,2012,20(1):19-19. 被引量:8
  • 2Fernandes ML, Oliveira WM, Santos MD, et al. Sedation for e- lectroencephalography with dexmedetomidine or chloral hy- drate: a comparative study on the qualitative and quantitative e- lectroencephalogram pattern [ J ]. J Neurosurg Anesthesiol, 2015,27 ( 1 ) :21-25.
  • 3Li BL,Yuan VM, Song XR,et al. Intranasal dexmedetomidine following failed chloral hydrate sedation in children [J].An- aesthesia, 2014,69 : 240 -244.
  • 4Mekitarian Filho E, Robinson F, De Carvalho WB, et al. In- tranasal dexmedetomidine for sedation for pediatric computed tomography imaging[ J]. J Pediatr,2015,166(5 ) :1313-1315.
  • 5Wilson ME,Karaoui M,Djasim LA,et al. The safety and effi- cacy of chloral hydrate sedation for pediatric ophthalmic proce- dures:a retrospective review [ J ]. J Pediatr Ophthalmol Strabis- mus ,2014,51 ( 3 ) : 154-159.
  • 6刘佳,姜清华,杨跃辉.水合氯醛溶液稳定性考察[J].实用药物与临床,2013,16(8):720-721. 被引量:13
  • 7Tow E, Drismll M, MacEneaney P, et al. Sedation with oral chloral hydrate in children undergoing MRI scanning [ J ]. Ir Med J,2008,101 (3) :80-82.
  • 8李碧莲,宋兴荣,李玉琼,黎苑明,刘齐兴.鼻内给予右美托咪定与口服水合氯醛在患儿CT检查中的有效性和安全性[J].临床麻醉学杂志,2013,29(9):859-862. 被引量:27
  • 9Liu JC, Verhulst S, Massar SA, et al. Sleep deprived and swea- ting it out:the effects of total sleep deprivation on skin con- ductance reactivity to psychosocial stress [J]. Sleep, 2015,38 (1) :155-159.
  • 10Kauss B, Green SM. Procedural sedation and analgesia in chil- dren [ J ]. Lancet,2006,367 (9512) :766-780.

二级参考文献15

  • 1陈新谦,金有豫,汤光.新编药物学[M]第15版.北京:人民卫生出版社,2004:3.
  • 2中华人民共和国卫生部药政局.中国医院制剂规范[M].第2版.北京:中国医药科枝出版社,1995:43-44.
  • 3Cortellazzi P, Lamperti M, Minati L, et al. Sedation of neu- rologically impaired children undergoing MRI: a sequential approach. Paediatr Anaesth, 2007,17 (7) : 630-636.
  • 4Low E, ODriscoll M, MacEneaney P, et al. Sedation with oral chloral hydrate in children undergoing MRI scanning. Ir Med J, 2008,101 (3) : 80-82.
  • 5Czapp M,Bankstahl JP,ZibelI G, et al. Brain penetration and anticonvulsant efficacy of intranasal phenobarbital in rats. Epilepsia, 2008,49 (7) : 1142-1150.
  • 6Yuen VM, Hui TW, Irwin MG, et al. A comparison of in- tranasal dexmedetomidine and oral midazoam for premediea- tion in pediatric anesthesia: a double-blinded randomized con- trolled trial. Anesth Analg, 2008,106 (8) : 1715-1721.
  • 7Ghati AM, Mahfouz AK, A1-Bahrani M. Preanesthetic medica- tion in children: A comparison of intranasal dexmedetomidine versus oral midazolam. Saudi J Anaesth, 2011,5(4) :387-391.
  • 8Yuen VM, Irwin MG, Hui TW, et al. A double-blind,crossover assessment of the sedative and analgesic effects of intranasal dexmedetomidine. Anesth Analg, 2007, 105 (2) : 374-380.
  • 9Yuen VM, Hui TW, Irwin MG, et al. Optimal timing for the administration of intranasa[ dexmedetomidine for premedica- tion in children. Anaesthesia, 2010,65 (9) : 922-929.
  • 10Iirola T, Vilo S, Manner T, et al. Bioavailability of dexme- detomidine after intranasal administration. Eur J Clin Phar- maeol, 2011,67(8) : 825-831.

共引文献45

同被引文献51

引证文献7

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部